ASIT Biotech S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,245.00
8,441.00
4,621.00
13,387.00
2,126.00
8,458
Total Accounts Receivable
61.00
102.00
279.00
326.00
244.00
281
Inventories
13.00
14.00
11.00
-
-
-
Other Current Assets
7.00
8.00
57.00
72.00
78.00
418
Total Current Assets
1,326.00
8,565.00
4,968.00
13,785.00
2,448.00
9,157
Net Property, Plant & Equipment
39.00
202.00
494.00
736.00
691.00
810
Long-Term Note Receivable
-
-
-
1,016.00
1,128.00
1,587
Other Assets
4.00
13.00
12.00
18.00
18.00
-
Total Assets
1,369.00
8,780.00
5,474.00
15,555.00
4,285.00
11,554
ST Debt & Current Portion LT Debt
-
-
4,232.00
-
-
Accounts Payable
351.00
858.00
1,611.00
1,707.00
1,264.00
Income Tax Payable
14.00
17.00
28.00
9.00
-
Other Current Liabilities
78.00
403.00
461.00
288.00
1,390.00
Total Current Liabilities
443.00
1,278.00
6,332.00
2,004.00
2,654.00
Long-Term Debt
884.00
-
-
-
-
Other Liabilities
-
70.00
-
419.00
432.00
Total Liabilities
1,327.00
1,348.00
6,332.00
2,423.00
3,086.00
Common Equity (Total)
42.00
7,432.00
858.00
13,132.00
1,199.00
Total Shareholders' Equity
42.00
7,432.00
858.00
13,132.00
1,199.00
Total Equity
42.00
7,432.00
858.00
13,132.00
1,199.00
Liabilities & Shareholders' Equity
1,369.00
8,780.00
5,474.00
15,555.00
4,285.00

About ASIT Biotech

View Profile
Address
Avenue Ariane 5
Woluwe-Saint-Lambert BU 1200
Belgium
Employees -
Website http://www.asitbiotech.com
Updated 07/08/2019
ASIT BioTech SA operates as clinical stage biopharmaceutical company. It focuses on the development and future commercialization of immunotherapy products for the treatment of allergies, based on its ASIT technology platform. The company was founded by Thierry Legon in May 1997 and is headquartered in Brussels, Belgium.